methoxyhydroxyphenylglycol has been researched along with Cognition Disorders in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (35.00) | 18.7374 |
| 1990's | 5 (25.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aerts, T; De Deyn, PP; Fransen, E; Gerritsen, MJ; Spikman, JM; Van Dam, D; van der Zee, S; van Laar, T; Vermeiren, Y | 1 |
| Imamura, Y; Kawashima, T; Kojima, N; Matsushima, J; Mizoguchi, Y; Monji, A; Nabeta, H; Watanabe, I; Yamada, S | 1 |
| Goto, N; Hayashi, K; Hori, H; Ikenouchi-Sugita, A; Kakeda, S; Korogi, Y; Moriya, J; Nakamura, J; Ueda, N; Umene-Nakano, W; Yoshimura, R | 1 |
| Hoeffer, CA; Klann, E; McBride, SM; Miyawaki, T; Sharma, A; Takayasu, Y; Zukin, RS | 1 |
| Furukawa, Y; Haraguchi, M; Imamura, Y; Ishii, H; Kojima, N; Kunitake, Y; Li, GY; Nabeta, H; Nizoguchi, Y; Tateishi, H; Watanabe, I; Yamada, S | 1 |
| Buechler, J; Oehler, J; Reuster, T; Winiecki, P | 1 |
| Duane, DD; Vermilion, KJ | 1 |
| Greenblatt, DJ; Hashim, A; Lajtha, A; Pomara, N; Sershen, H; Sidtis, JJ; Wesnes, K; Willoughby, LM | 1 |
| Mair, RG; McEntee, WJ | 2 |
| Langlais, PJ; Mair, RG; McEntee, WJ | 1 |
| de Leon, MJ; Ferris, SH; Gershon, S; Mann, JJ; Neophytides, A; Stanley, M | 1 |
| Apter, S; Davidson, M; Davis, KL; Harvey, PD; Kahn, RS; Keefe, RS; Mohs, RC; Neale, JM | 1 |
| Borrelli, D; Griffin, M; Mirin, SM; Samson, JA; Schildkraut, JJ | 1 |
| Bardgett, ME; Csernansky, JG; Miller, K; Sheline, YI | 1 |
| Goldstein, DS; Holmes, C; Peskind, ER; Raskind, MA | 1 |
| Bourgeois, F; Buyse, M; Goldman, S; Hildebrand, J; Przedborski, S | 1 |
| Cote, L; Mayeux, R; Sano, M; Stern, Y; Williams, JB | 1 |
| Benton, JS; Bowen, DM; Francis, PT; Mann, DM; Neary, D; Palmer, AM; Snowden, JS | 1 |
| Angrist, B; Gershon, S; Sathananthan, G; Wilk, S | 1 |
2 review(s) available for methoxyhydroxyphenylglycol and Cognition Disorders
| Article | Year |
|---|---|
Cognition and affect in patients with cervical dystonia with and without tremor.
Topics: Affect; Arousal; Cholinergic Antagonists; Cognition; Cognition Disorders; Humans; Learning Disabilities; Mental Disorders; Methoxyhydroxyphenylglycol; Neuropsychological Tests; Psychomotor Performance; Torticollis; Tremor | 2004 |
Korsakoff's psychosis: noradrenergic systems and cognitive impairment.
Topics: Alcohol Amnestic Disorder; Animals; Attention; Behavior, Animal; Brain; Cognition Disorders; Humans; Mental Recall; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Norepinephrine; Perception; Retention, Psychology | 1983 |
2 trial(s) available for methoxyhydroxyphenylglycol and Cognition Disorders
| Article | Year |
|---|---|
Effects of acute lorazepam administration on aminergic activity in normal elderly subjects: relationship to performance effects and apolipoprotein genotype.
Topics: Aged; Analysis of Variance; Anti-Anxiety Agents; Apolipoprotein E4; Apolipoproteins; Apolipoproteins E; Cognition; Cognition Disorders; Genotype; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Lorazepam; Methoxyhydroxyphenylglycol; Middle Aged; Motor Activity; Regression Analysis | 2004 |
Cognitive enhancement in Korsakoff's psychosis by clonidine: a comparison with L-dopa and ephedrine.
Topics: Alcohol Amnestic Disorder; Attention; Biogenic Amines; Brain Chemistry; Clonidine; Cognition Disorders; Ephedrine; Humans; Levodopa; Male; Memory; Methoxyhydroxyphenylglycol; Perception; Psychomotor Performance | 1986 |
16 other study(ies) available for methoxyhydroxyphenylglycol and Cognition Disorders
| Article | Year |
|---|---|
Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.
Topics: Aged; Biogenic Monoamines; Biomarkers; Cognition Disorders; Cognitive Dysfunction; Diagnosis, Differential; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Lewy Body Disease; Male; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Retrospective Studies | 2018 |
Belief in life after death, salivary 3-methoxy-4-hydroxyphenylglycol, and well-being among older people without cognitive impairment dwelling in rural Japan.
Topics: Aged; Aged, 80 and over; Attitude to Death; Cognition Disorders; Ethylene Glycols; Female; Humans; Japan; Male; Methoxyhydroxyphenylglycol; Personal Satisfaction; Phenols; Religion; Rural Population; Spirituality | 2015 |
Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Cognition Disorders; Female; Frontal Lobe; gamma-Aminobutyric Acid; Homovanillic Acid; Humans; Magnetic Resonance Spectroscopy; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurons; Neuropsychological Tests; Norepinephrine; Schizophrenia; Young Adult | 2009 |
Dysregulation of mTOR signaling in fragile X syndrome.
Topics: Adaptor Proteins, Signal Transducing; Animals; CA1 Region, Hippocampal; Carrier Proteins; Cell Cycle Proteins; Cognition Disorders; Disease Models, Animal; Eukaryotic Initiation Factor-4A; Eukaryotic Initiation Factors; Excitatory Postsynaptic Potentials; Fragile X Mental Retardation Protein; Fragile X Syndrome; Gene Expression Regulation; Immunoprecipitation; In Vitro Techniques; Long-Term Synaptic Depression; Methoxyhydroxyphenylglycol; Mice; Mice, Knockout; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Receptors, Metabotropic Glutamate; Serine; Signal Transduction; Sirolimus | 2010 |
Baseline saliva level of 3-methoxy-4-hydroxyphenylglycole (MHPG) associates with a consequent cognitive decline in non-demented elderly subjects: three-years follow-up study.
Topics: Aged; Aged, 80 and over; Aging; Cognition Disorders; Cohort Studies; Female; Humans; Male; Mental Status Schedule; Methoxyhydroxyphenylglycol; Neuropsychological Tests; Saliva; Sex Factors; Statistics, Nonparametric | 2012 |
Influence of reboxetine on salivary MHPG concentration and cognitive symptoms among patients with alcohol-related Korsakoff's syndrome.
Topics: Alcohol Amnestic Disorder; Cognition Disorders; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Morpholines; Multivariate Analysis; Reboxetine; Saliva; Statistics, Nonparametric | 2003 |
Neurochemical pathology in Korsakoff's psychosis: implications for other cognitive disorders.
Topics: Alcohol Amnestic Disorder; Cognition Disorders; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Psychological Tests | 1984 |
Central amine metabolism in Alzheimer's disease: in vivo relationship to cognitive deficit.
Topics: Aged; Alzheimer Disease; Blood Platelets; Cognition Disorders; Dementia; Glycols; Homovanillic Acid; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Phenylacetates; Tomography, X-Ray Computed | 1981 |
Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function.
Topics: Adult; Cerebral Cortex; Cognition Disorders; Discrimination Learning; Dopamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Recall; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Norepinephrine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Serotonin; Wechsler Scales | 1994 |
Urinary MHPG and clinical symptoms in patients with unipolar depression.
Topics: Adult; Body Weight; Cognition Disorders; Depressive Disorder; Dexamethasone; Female; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales; Psychomotor Disorders; Sleep Wake Disorders; Thyrotropin; Thyroxine; Triiodothyronine | 1994 |
Higher cerebrospinal fluid MHPG in subjects with dementia of the Alzheimer type. Relationship with cognitive dysfunction.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Serotonin; Severity of Illness Index | 1998 |
Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Aged; Aging; Alzheimer Disease; Antimetabolites; Catechols; Chromatography, High Pressure Liquid; Clonidine; Cognition Disorders; Dihydroxyphenylalanine; Extracellular Space; Female; Humans; Locus Coeruleus; Male; Methoxyhydroxyphenylglycol; Neurons; Neuropsychological Tests; Norepinephrine; Yohimbine | 1999 |
Reproducibility of monoamine metabolite measurements in human cerebrospinal fluid.
Topics: Adult; Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Cognition Disorders; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Reproducibility of Results | 1990 |
Clinical and biochemical correlates of bradyphrenia in Parkinson's disease.
Topics: Aged; Alzheimer Disease; Arousal; Attention; Biogenic Amines; Cognition Disorders; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Parkinson Disease | 1987 |
Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Catecholamines; Cerebral Cortex; Choline O-Acetyltransferase; Cognition Disorders; Dopamine; Female; Homovanillic Acid; Humans; In Vitro Techniques; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Serotonin | 1987 |
Amphetamine psychosis: behavioral and biochemical aspects.
Topics: Adolescent; Adult; Affect; Alcoholism; Amphetamine; Brain; Cognition Disorders; Delusions; Depression; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Ethylene Glycols; Hallucinations; Haloperidol; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Psychoses, Substance-Induced; Receptors, Drug; Schizophrenia; Schizophrenic Language; Schizophrenic Psychology; Stereoisomerism | 1974 |